5ZCX
Structure of T20/N39
5ZCX の概要
| エントリーDOI | 10.2210/pdb5zcx/pdb |
| 分子名称 | Envelope glycoprotein, Envelope glycoprotein gp160 (3 entities in total) |
| 機能のキーワード | 6-hb, helices, sugar binding protein |
| 由来する生物種 | Human immunodeficiency virus 1 詳細 |
| タンパク質・核酸の鎖数 | 6 |
| 化学式量合計 | 26153.30 |
| 構造登録者 | |
| 主引用文献 | Zhang, X.,Ding, X.,Zhu, Y.,Chong, H.,Cui, S.,He, J.,Wang, X.,He, Y. Structural and functional characterization of HIV-1 cell fusion inhibitor T20. AIDS, 33:1-11, 2019 Cited by PubMed Abstract: The peptide drug T20 (enfuvirtide), derived from the C-terminal heptad repeat region of HIV-1 gp41, is the only membrane fusion inhibitor available for treatment of viral infection; however, its mechanism of action remains elusive and its structural basis is lacking. PubMed: 30096076DOI: 10.1097/QAD.0000000000001979 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.299 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






